This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A union that represents more than 11,000 FDA employees nationwide — the National...
Two new memos update federal AI policy, which the White House says will accelera...
Amgen has enjoyed a monopoly on its blockbuster inflammatory disease drug Enbrel...
On Monday, Pfizer announced it had given up on danuglipron, the company's closel...
Pfizer said a patient dosed with danuglipron developed potential drug-induced li...
For the 164th episode of the Healthcare IT Today Podcast, we are talking about 2...
The government is fighting in court for a plan to cut spending on overhead resea...
The decade ahead will test our healthcare system like never before. But within t...
The following is a guest article by Ruston Miles, Founder of Bluefin In today’s ...
Merger Creates Nation’s Most Comprehensive High-Acuity Care Platform, Helping Mo...
By moving beyond adherence and drug interactions to a holistic, outcomes-driven ...
Creates Industry Leader in Business Continuity and Data Accessibility for Hospit...
Ironwood Pharmaceuticals is now working with Goldman Sachs in its hunt for compa...
Commerce Secretary Howard Lutnick has indicated more specific timelines as to wh...